MEDICALCONTROL INC
POS AM, 1998-03-26
HOSPITAL & MEDICAL SERVICE PLANS
Previous: TIG HOLDINGS INC, DEF 14A, 1998-03-26
Next: RIVIERA HOLDINGS CORP, SC 13D/A, 1998-03-26



<PAGE>
 
          As filed with the Securities and Exchange Commission on March 26, 1998
                                            Registration Statement No. 333-05025

- --------------------------------------------------------------------------------

                      SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.20549

                               ________________
                        POST EFFECTIVE AMENDMENT NO. 1
                                      TO 
                                   FORM S-3
                            REGISTRATION STATEMENT
                                     UNDER
                          THE SECURITIES ACT OF 1933
                               ________________

                             MEDICALCONTROL, INC.
            (Exact name of registrant as specified in its charter)

                                   DELAWARE
                          (State or other jurisdiction
                       of incorporation or organization)

                                  75-2297429
                     (I.R.S. Employer Identification No.)

                               ________________

                        8625 KING GEORGE DR., SUITE 300
                              DALLAS, TEXAS 75235
                                (214) 630-6368
              (Address, including zip code, and telephone number,
       including area code, of registrant's principal executive offices)

                               ________________

             JOHN WARD HUNT, PRESIDENT AND CHIEF EXECUTIVE OFFICER
                             MEDICALCONTROL, INC.
                        8625 KING GEORGE DR., SUITE 300
                              DALLAS, TEXAS 75235
                                (214) 630-6368
          (Name, address, including zip code, and telephone number, 
       including are code, of registrant's principal executive offices)

                               ________________

                       Copies of all communications to:

- --------------------------------------------------------------------------------
                           STEPHANIE L. MCVAY, ESQ.
                             MEDICALCONTROL, INC.
                        8625 KING GEORGE DR. SUITE 300
                              DALLAS, TEXAS 75235
                           TELEPHONE: (214) 630-6368
                           FACSIMILE: (214) 905-5155
- --------------------------------------------------------------------------------
<PAGE>

     Approximate date of proposed sale to the public: There is no proposed sale
to the public.

     If the only securities being registered on this Form are being offered 
pursuant to dividend or interested reinvestment plans, please check the 
following box. [_]

     If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 
1933, other than securities offered only in connection with dividend or 
interest reinvestment plans, check the following box. [_]

     If this Form is a post-effective amendment filed pursuant to Rule 462(c) 
under the Securities Act, check the following box and list the Securities Act 
registration statement number of the earlier effective registration statement 
for the same offering. [_]

     THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION SHALL
THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE SECURITIES
ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH
DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A), MAY DETERMINE.

     

<PAGE>
 
                                  SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, as amended, the
Registrant certifies that it has reasonable grounds to believe that it meets 
all of the requirements for filing on Form S-3 and has dully caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Dallas, State of Texas, on March 26, 1998.

                                             Registrant:
                                             MEDICALCONTROL, INC.
                                   
                                             By: /s/ John Ward Hunt
                                                -----------------------------
                                                John Ward Hunt, President

     Pursuant to the requirements of the Securities Act of 1933, as amended, 
this Registration Statement has been signed by the following persons in the 
capacities and on the dates indicated.

<TABLE> 
<CAPTION> 
     Name                               Title                                        Date
     ----                               -----                                        ----
<S>                                     <C>                                        <C>   
     /s/ J. Ward Hunt                   President, Chief Executive Officer         3/26/98
- ------------------------------    
John Ward Hunt                          Chief Financial Officer, Chief
                                        Accounting Officer and Chairman of
                                        the Board of Directors   

     /s/ David A. Hanson                Vice President, Finance and Accounting     3/26/98
- ------------------------------     
Daivd A. Hanson                         (Chief Accounting Officer)    

          *                             Executive Vice President and Chief
- ------------------------------                    
Robert O. Brooks                         Operating Officer

          *                             Director
- ------------------------------     
Robert W. Philip

          *                             Director
- ------------------------------     
William L. Amos, Jr., M.D.

          *                             Director 
- ------------------------------     
D. Samuel Coats

*By: /s/ J. Ward Hunt
   ---------------------------
   J. Ward Hunt, Attorney-In-Fact  
</TABLE> 



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission